223 related articles for article (PubMed ID: 33660561)
41. Efficacy of freeze-dried amnion graft following hysteroscopic adhesiolysis of severe intrauterine adhesions.
Gan L; Duan H; Sun FQ; Xu Q; Tang YQ; Wang S
Int J Gynaecol Obstet; 2017 May; 137(2):116-122. PubMed ID: 28170094
[TBL] [Abstract][Full Text] [Related]
42. Asherman's Syndrome: it may not be all our fault.
Santamaria X; Isaacson K; Simón C
Hum Reprod; 2018 Aug; 33(8):1374-1380. PubMed ID: 31986212
[TBL] [Abstract][Full Text] [Related]
43. Oxidized, Regenerated Cellulose Adhesion Barrier Plus Intrauterine Device Prevents Recurrence After Adhesiolysis for Moderate to Severe Intrauterine Adhesions.
Cai H; Qiao L; Song K; He Y
J Minim Invasive Gynecol; 2017 Jan; 24(1):80-88. PubMed ID: 27742483
[TBL] [Abstract][Full Text] [Related]
44. Preoperative sonographic measurement of endometrial pattern predicts outcome of surgical repair in patients with severe Asherman's syndrome.
Schlaff WD; Hurst BS
Fertil Steril; 1995 Feb; 63(2):410-3. PubMed ID: 7843453
[TBL] [Abstract][Full Text] [Related]
45. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study.
Lin X; Wei M; Li TC; Huang Q; Huang D; Zhou F; Zhang S
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):512-6. PubMed ID: 23932377
[TBL] [Abstract][Full Text] [Related]
46. Gynecologic surgery and adhesion prevention. Asherman's syndrome.
Neuwirth RS
Prog Clin Biol Res; 1993; 381():187-90. PubMed ID: 8316561
[TBL] [Abstract][Full Text] [Related]
47. Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system.
Zikopoulos KA; Kolibianakis EM; Platteau P; de Munck L; Tournaye H; Devroey P; Camus M
Reprod Biomed Online; 2004 Jun; 8(6):720-5. PubMed ID: 15169591
[TBL] [Abstract][Full Text] [Related]
48. Auto-Cross-Linked Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions after Hysteroscopic Adhesiolysis: A Randomized Controlled Trial.
Zhou Q; Shi X; Saravelos S; Huang X; Zhao Y; Huang R; Xia E; Li TC
J Minim Invasive Gynecol; 2021 Feb; 28(2):307-313. PubMed ID: 32681996
[TBL] [Abstract][Full Text] [Related]
49. Clinical characteristics and reproductive outcome following hysteroscopic adhesiolysis of patients with intrauterine adhesion--a retrospective study.
Liu X; Duan H; Wang Y
Clin Exp Obstet Gynecol; 2014; 41(2):144-8. PubMed ID: 24779239
[TBL] [Abstract][Full Text] [Related]
50. Concomitant hysteroscopy and hysterography in Asherman's syndrome.
Lancet M; Mass N
Int J Fertil; 1981; 26(4):267-72. PubMed ID: 6120907
[TBL] [Abstract][Full Text] [Related]
51. Prevention of intrauterine adhesions.
Emingr Michal; Halaj Matúš; Malčák Michal; Hanáček Jiří
Ceska Gynekol; 2023; 88(3):210-213. PubMed ID: 37344187
[TBL] [Abstract][Full Text] [Related]
52. [Asherman's syndrome : management after curettage following a postnatal placental retention and literature review].
Tchente NC; Brichant G; Nisolle M
Rev Med Liege; 2018 Oct; 73(10):508-512. PubMed ID: 30335256
[TBL] [Abstract][Full Text] [Related]
53. The Diagnosis and Management of Asherman's Syndrome Developed after Cesarean Section and Reproductive Outcome.
Cenksoy PO; Ficicioglu C; Yesiladali M; Kizilkale O
Case Rep Obstet Gynecol; 2013; 2013():450658. PubMed ID: 23840987
[TBL] [Abstract][Full Text] [Related]
54. Preventive effect of oral mucosal epithelial cell sheets on intrauterine adhesions.
Kuramoto G; Takagi S; Ishitani K; Shimizu T; Okano T; Matsui H
Hum Reprod; 2015 Feb; 30(2):406-16. PubMed ID: 25475585
[TBL] [Abstract][Full Text] [Related]
55. Genital tuberculosis: an important cause of Asherman's syndrome in India.
Sharma JB; Roy KK; Pushparaj M; Gupta N; Jain SK; Malhotra N; Mittal S
Arch Gynecol Obstet; 2008 Jan; 277(1):37-41. PubMed ID: 17653564
[TBL] [Abstract][Full Text] [Related]
56. Factors That Impact Fertility after Hysteroscopic Adhesiolysis for Intrauterine Adhesions and Amenorrhea: A Retrospective Cohort Study.
Chen L; Xiao S; He S; Tian Q; Xue M
J Minim Invasive Gynecol; 2020 Jan; 27(1):54-59. PubMed ID: 30880159
[TBL] [Abstract][Full Text] [Related]
57. Hysteroscopic Intrauterine Adhesiolysis Using a Blunt Spreading Dissection Technique With Double-action Forceps.
Huang H; Cheng C; Johnson G; Wang R; Xue M; Zhang A; Xu D; Guan X
J Minim Invasive Gynecol; 2018; 25(4):583-584. PubMed ID: 29038040
[TBL] [Abstract][Full Text] [Related]
58. Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell Therapies.
Hou X; Liu Y; Streuli I; Dällenbach P; Dubuisson J; Ansaldi Y; Pluchino N
Curr Stem Cell Res Ther; 2019; 14(6):454-459. PubMed ID: 30760192
[TBL] [Abstract][Full Text] [Related]
59. Meta-analysis on the use of hyaluronic acid gel to prevent recurrence of intrauterine adhesion after hysteroscopic adhesiolysis.
Fei Z; Bin Z; Xin X; Fei H; Yuechong C
Taiwan J Obstet Gynecol; 2019 Nov; 58(6):731-736. PubMed ID: 31759520
[TBL] [Abstract][Full Text] [Related]
60. Bone Marrow-Derived Stem Cell (BMDSC) transplantation improves fertility in a murine model of Asherman's syndrome.
Alawadhi F; Du H; Cakmak H; Taylor HS
PLoS One; 2014; 9(5):e96662. PubMed ID: 24819371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
